'Undruggable' To Druggable: A New Target For Cancer Drug Development

Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

http://www.medilexicon.com/medicalnews.php?newsid=262114